Andrew Shaoyu Chen is a consultant of Life Sciences & Healthcare Practice Group of Global Law Office, with over 20 years of experience in pharmaceutical and medical device regulatory laws in China and the U.S. Andrew has been effectively assisting life sciences companies doing business in China and the U.S. to resolve the most challenging legal and regulatory issues, set out critical strategies and implementation plans, respond to ever-increasing government oversight, mitigate enforcement risks, and successfully conduct product licensing and collaboration, clinical trial, product registration, manufacturing, sales and marketing, pharmacovigilance, and pricing and reimbursement.

Andrew has also been actively assisting, on a pro bono basis, the China National Medical Products Administration (NMPA, formerly known as CFDA and SFDA) and various academic organizations to better understand the U.S. FDA framework, and accelerate China’s pharmaceutical and medical device regulatory systems and industry practices to align with that of the leading countries in the world.

Andrew Chen previously served as Assistant Chief Counsel at the U.S. Food and Drug Administration (FDA) Headquarters in Rockville, Maryland (2000–2004), and as Senior Counsel at Amgen’s Global Headquarters in Thousand Oaks, California (2006–2010). Prior to joining Global Law Office, Andrew also served as a partner in the Beijing and Shanghai offices of two preeminent US law firms (2011-2024).

District of Columbia

University of Nebraska College of Law, J.D.

Peking University, LL.B.